Role of tissue factor in pregnancy complications: Crosstalk between coagulation and inflammation

Thrombosis Research

Volumn 127, Issue SUPPL. 3, 2011, Pages

  Girardi, Guillermina ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Preeclampsia; Recurrent miscarriages; Tissue factor

Indexed keywords

ANGIOGENESIS INHIBITOR; CELL ADHESION MOLECULE; COMPLEMENT COMPONENT C5A; CYTOKINE; FIBRIN; MONOCLONAL ANTIBODY; PHOSPHOLIPID ANTIBODY; PRAVASTATIN; PROTEINASE ACTIVATED RECEPTOR; PROTEINASE ACTIVATED RECEPTOR 2; REACTIVE OXYGEN METABOLITE; THROMBOPLASTIN; THROMBOPLASTIN ANTIBODY; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG; VASCULOTROPIN;

ALBUMINURIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD CLOTTING; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DECIDUA; FEMALE; FETUS DISEASE; FIBRIN DEPOSITION; GENE DELETION; GLOMERULOPATHY; HUMAN; INFLAMMATION; INFLAMMATORY CELL; KNOCKOUT MOUSE; MOLECULAR INTERACTION; MOUSE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PHAGOCYTOSIS; PLACENTA DISORDER; PLACENTA PERFUSION; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PRIORITY JOURNAL; REACTOR CASCADE; RECEPTOR DOWN REGULATION; RESPIRATORY BURST; SPONTANEOUS ABORTION; THROMBOGENESIS; TROPHOBLAST; TROPHOBLASTIC DISEASE;

ABORTION, HABITUAL; ANIMALS; ANTICHOLESTEREMIC AGENTS; BLOOD COAGULATION; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; FEMALE; HUMANS; INFLAMMATION; MICE; PRAVASTATIN; PRE-ECLAMPSIA; PREGNANCY; THROMBOPLASTIN;

EID: 79251493786     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(11)70012-3     Document Type: Article

References (26)

1. LA Barbour, J Pickard Controversies in thromboembolic disease during pregnancy: a critical review Obstet Gynecol 86 4 1995 621 633
2. B Brenner Thrombophilia in pregnancy and its role in abortion Women's Health (Lond Engl) 1 1 2005 35 38
3. CT Esmon Crosstalk between inflammation and thrombosis Maturitas 47 4 2004 305 314
4. U Amara, MA Flierl, D Rittirsch, A Klos, H Chen, B Acker Molecular intercommunication between the complement and coagulation systems J Immunol 185 9 2010 5628 5636
5. MM Markiewski, B Nilsson, KN Ekdahl, TE Mollnes, JD Lambris Complement and coagulation: strangers or partners in crime? Trends Immunol 28 4 2007 184 192
6. M Markiewski, JD Lambris The role of complement in inflammatory diseases - from behind the scenes into the spotlight AmJ Pathol 171 2007 715 717
7. CT Esmon The impact of the inflammatory response on coagulation Thromb Res 114 2004 321 327
8. G Ruiz-Irastorza, MA Khamashta, G Castellino, GR Hughes Systemic lupus erythematosus Lancet 357 2001 1027 1032
9. G Girardi, J Berman, P Redecha, L Spruce, JM Thurman, D Kraus Complement C5a receptors and neutrophils mediate fetal njury in the antiphospholipid syndrome J Clin Invest 112 2003 1644 1654
10. P Redecha, R Tilley, M Tencati, JE Salmon, D Kirchhofer, N Mackman Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody induced fetal injury Blood 110 7 2007 2423 2431
11. E Camerer, W Huang, SR Coughlin Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor Vila Proc Natl Acad Sci U S A 97 2000 5255 5260
12. W Ruf, A Dorfleutner, M Riewald Specificity of coagulation factor signaling J Thromb Haemost 1 2003 1495 1503
13. K Ritis, M Doumas, D Mastellos, A Micheli, S Giaglis, P Magotti A novel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways J Immunol 177 2006 4794 4802
14. RA Roubey Tissue factor pathway and the antiphospholipid syndrome J Autoimmun 15 2000 217 220
15. G Girardi, P Redecha, JE Salmon Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation Nat Med 10 11 2004 1222 1226
16. NW Bunnett Protease-activated receptors: how proteases signal to cells to cause inflammation and pain Semin Thromb Hemost 32 2006 39 48
17. GL Howells, MG Macey, C Chinni, L Hou, MT Fox, P Harriot J Cell Sci 110 1997 881 887
18. P Redecha, CW Franzke, W Ruf, N Mackman, G Girardi Neutrophil activation by the tissue factor/Factor VIIa/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome J Clin Invest 118 10 2008 3453 3461
19. A Ahmed, J Singh, Y Khan, SV Seshan, G Girardi A new mouse model to explore therapies for preeclampsia PLoS One 5 10 2010 e13663
20. G Girardi, D Yarilin, JM Thurman, VM Holers, J Salmon Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction J Exp Med 203 2006 2165 2175
21. P Redecha, N van Rooijen, D Torry, G Girardi Pravastatin prevents miscarriages in mice: role of tissue factor in placental and fetal injury Blood 113 17 2009 4101 4109
22. J Ahamed, F Niessen, T Kurokawa, YK Lee, G Bhattacharjee, JH Morrissey Regulation of macrophage procoagulant responses by the tissue factor cytoplasmic domain in endotoxemia Blood 109 2007 5251 5259
23. O Erez, R Romero, D Hoppensteadt, NG Than, J Fareed, S Mazaki-Tovi Tissue factor and its natural inhibitor in pre-eclampsia and SGA J Matern Fetal Neonatal Med 21 2008 855 861
24. KI Paraskevas, V Stathopoulos, DP Mikhailidis Emerging indications for statins: a pluripotent family of agents with several potential applications Curr Pharm Des 13 2007 3622 3636
25. Y Kunieda, K Nakagawa, H Nishimura, H Kato, N Ukimura, S Yano HMG CoA reductase inhibitor suppresses the expression of tissue factor and plasminogen activator inhibitor-1 induced by angiotensin II in cultured rat aortic endothelial cells Thromb Res 110 2003 227 234
26. PS Pollack, KE Shields, DM Burnett, MJ Osborne, ML Cunningham, ME Stepanavage Pregnancy outcomes after maternal exposure to simvastatin and lovastatin Birth Defects Res Clin Mol Teratol 73 2005 888 896